KalVista Pharmaceuticals (KALV) Stock Chart & Stock Price History → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free KALV Stock Alerts $12.02 +0.34 (+2.91%) (As of 01:51 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KalVista Pharmaceuticals Stock Price Performance5 Day Performance-0.41%1 Month Performance-0.50%3 Month Performance-16.30%6 Month Performance+47.30%Year-To-Date Performance-1.88%1 Year Performance+21.29% Receive KALV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution KALV Stock Chart for Monday, June, 10, 2024 KALV Chart by TradingView KalVista Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$11.85$11.68-1.43%$11.80$11.35243,242 shs$492.78 million06/06/2024$12.07$11.85-1.82%$12.08$11.76104,230 shs$499.95 million06/05/2024$11.86$12.07+1.77%$12.19$11.77172,222 shs$509.23 million06/04/2024$12.11$11.86-2.06%$12.12$11.62219,491 shs$500.37 million06/03/2024$11.67$12.11+3.77%$12.15$11.62548,881 shs$510.92 million05/31/2024$11.25$11.67+3.73%$11.99$11.30234,800 shs$492.36 million Get the Latest News and Ratings for KALV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$11.15$11.25+0.90%$11.30$11.05150,971 shs$474.64 million05/29/2024$11.08$11.15+0.63%$11.30$10.95246,274 shs$470.42 million05/28/2024$11.30$11.08-1.95%$11.50$10.93362,737 shs$467.44 million05/27/2024$11.30$11.30$11.45$11.15242,500 shs$476.75 million05/24/2024$11.29$11.30+0.09%$11.44$11.15242,589 shs$476.75 million05/23/2024$11.69$11.29-3.42%$11.69$10.92548,928 shs$476.33 million05/22/2024$11.61$11.69+0.69%$11.86$11.47368,322 shs$493.20 million05/21/2024$11.88$11.61-2.27%$11.98$11.32432,719 shs$489.83 million05/20/2024$11.92$11.88-0.34%$11.98$11.43379,115 shs$501.22 million05/17/2024$12.07$11.92-1.24%$12.06$11.70337,564 shs$502.91 million05/16/2024$12.01$12.07+0.50%$12.27$11.76306,591 shs$509.23 million05/15/2024$12.49$12.01-3.84%$12.92$11.93272,270 shs$506.70 million05/14/2024$12.00$12.49+4.08%$12.55$12.06235,948 shs$526.95 million05/13/2024$12.08$12.00-0.66%$12.43$11.91206,932 shs$506.28 million05/10/2024$12.09$12.08-0.08%$12.15$11.79217,887 shs$509.63 million05/09/2024$12.06$12.09+0.25%$12.21$11.98128,987 shs$510.05 million05/08/2024$12.19$12.06-1.07%$12.25$12.00160,775 shs$508.81 million05/07/2024$12.14$12.19+0.41%$12.28$11.97131,214 shs$514.30 million05/06/2024$12.13$12.14+0.08%$12.22$12.02193,066 shs$512.19 million05/03/2024$12.17$12.13-0.33%$12.48$11.96199,656 shs$511.77 million05/02/2024$12.18$12.17-0.08%$12.30$11.78571,496 shs$513.45 million05/01/2024$11.35$12.18+7.31%$12.52$11.35482,057 shs$513.87 million04/30/2024$11.01$11.35+3.09%$11.40$10.92321,782 shs$478.86 million04/29/2024$10.78$11.01+2.13%$11.19$10.88194,250 shs$464.51 million04/26/2024$10.49$10.78+2.76%$10.81$10.27241,417 shs$454.81 million04/25/2024$10.35$10.49+1.35%$10.52$10.11363,774 shs$442.57 million04/24/2024$11.21$10.35-7.67%$11.18$10.32482,316 shs$436.67 million04/23/2024$11.44$11.21-2.01%$11.71$11.19192,444 shs$472.95 million04/22/2024$11.57$11.44-1.12%$11.78$11.36289,249 shs$482.65 million04/19/2024$11.50$11.57+0.61%$11.78$11.27346,976 shs$488.14 million04/18/2024$11.65$11.50-1.29%$11.75$11.28408,653 shs$485.19 million04/17/2024$11.88$11.65-1.94%$11.94$11.65298,645 shs$491.51 million04/16/2024$11.74$11.88+1.19%$12.16$11.48489,733 shs$501.22 million04/15/2024$11.89$11.74-1.26%$12.01$11.50313,460 shs$495.31 millionIt's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution04/12/2024$12.10$11.89-1.74%$12.05$11.70237,891 shs$501.64 million04/11/2024$11.93$12.10+1.42%$12.26$11.71312,126 shs$510.48 million04/10/2024$11.81$11.93+1.02%$11.94$11.37554,624 shs$503.30 million04/09/2024$11.04$11.81+6.97%$11.85$11.02571,645 shs$498.26 million04/08/2024$11.09$11.04-0.45%$11.20$10.82210,204 shs$465.78 million04/05/2024$11.21$11.09-1.07%$11.38$10.97184,357 shs$467.89 million04/04/2024$11.26$11.21-0.44%$11.42$10.95500,277 shs$472.95 million04/03/2024$11.04$11.26+1.99%$11.34$10.81220,866 shs$475.06 million04/02/2024$11.40$11.04-3.16%$11.48$10.921.47 million shs$465.78 million04/01/2024$11.86$11.40-3.88%$11.79$11.03817,261 shs$480.97 million03/29/2024$11.86$11.86$12.46$10.922.15 million shs$500.37 million03/28/2024$11.07$11.86+7.14%$12.46$10.922.15 million shs$500.37 million03/27/2024$11.11$11.07-0.36%$11.41$10.97266,044 shs$467.04 million03/26/2024$11.13$11.11-0.18%$11.38$10.70520,288 shs$468.73 million03/25/2024$11.85$11.13-6.08%$11.84$11.04514,062 shs$499.93 million03/22/2024$12.15$11.85-2.47%$12.29$11.75270,704 shs$499.95 million03/21/2024$12.23$12.15-0.65%$12.70$12.07280,289 shs$512.61 million03/20/2024$11.84$12.23+3.29%$12.24$11.75446,784 shs$515.98 million03/19/2024$11.99$11.84-1.25%$12.38$11.65454,865 shs$499.53 million03/18/2024$11.93$11.99+0.50%$12.35$11.58560,270 shs$505.86 million03/15/2024$12.43$11.93-4.02%$12.56$11.87792,468 shs$503.33 million03/14/2024$12.49$12.43-0.48%$12.57$12.12458,750 shs$429.58 million03/13/2024$12.49$12.49$12.78$12.42408,314 shs$431.65 million03/12/2024$13.10$12.49-4.66%$13.07$12.31570,981 shs$431.65 million03/11/2024$14.36$13.10-8.77%$14.44$13.06664,015 shs$452.72 million Related Companies: ABUS Stock Price Chart ALIM Stock Price Chart BCRX Stock Price Chart ARVN Stock Price Chart ZLAB Stock Price Chart CPRX Stock Price Chart GLPG Stock Price Chart KROS Stock Price Chart EVO Stock Price Chart PTGX Stock Price Chart Receive KALV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALV) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.